coronavirus vaccine plans to use Turkey in the fight against the pandemic have been produced coronavac display centers in Beijing.
Turkey, a Chinese biopharmaceutical company coronavirus vaccine developed by Sinovac coronavac't which ordered 50 million doses. Sinovac coronavirus vaccine, Phase 3 clinical trial in Turkey was carried out China's first Covidien-19 vaccine. Stage 3 trials of the vaccine were also made in Indonesia and Brazil and successful results were recorded. The Sinovac company recently opened its second production line with an investment of US $ 500 million. Thus, the vaccine production capacity is expected to reach 600 million per year.
Vaccines produced in the center will be transported from the warehouses to the airport by vehicles. Authorities reported that the first group shipment included 1 million 300 thousand doses of vaccine.
One of the biggest advantages of the Sinovac vaccine is that it can be stored in a standard refrigerator at 2-8 degrees Celsius, while the vaccines can thus be protected without the need for special coolers. This feature of the vaccine is seen as an important advantage in preventing the global epidemic.
on the special cold container where the vaccines will be sent to Turkey as a Turkish "without Masks smile, get rid of the distance" message by posters were pasted. Sinovac coronavirus vaccines have entered the country after Turkey Pharmaceuticals and Medical Devices Agency (TİTCK) and Directorate General of Public Health will be examined by experts for 2 weeks.
coronavac vaccine to health workers in Turkey, all Turkish citizens, including the priority to high-risk groups and professional groups which potentially can be applied to spread infection free.
Hibya News Agency